Autologous adipose-derived mesenchymal stromal cells for the treatment of osteoarthritis
The aim of this study is to asses the safety of a single injection of autologous adipose-derived mesenchymal stromal cells (MSCs) in patients with moderate or severe osteoarthritis of the knee.
Read More
Product Information for
Autologous adipose-derived mesenchymal stromal cells for the treatment of osteoarthritis